老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aurinia Pharmaceuticals Inc

8.21
+0.01000.12%
盤前：8.01-0.2000-2.44%04:20 EDT
成交量：75.11萬
成交額：619.41萬
市值：11.22億
市盈率：205.25
高：8.38
開：8.21
低：8.20
收：8.20
資料載入中...
總覽公司新聞公告
2021/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/25

重要事件披露

8-K - Current report
2020/10/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

年度報告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多